» Articles » PMID: 18550210

A Pilot Quality-of-life Instrument for Pruritus

Overview
Specialty Dermatology
Date 2008 Jun 14
PMID 18550210
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We sought to develop a validated, reliable pruritus-specific quality-of-life (QOL) instrument, ItchyQoL.

Methods: From 21 in-depth interviews with patients with pruritus, we developed 22 pruritus-specific items, and hypothesized 3 major constructs that explain the way pruritus affects patients' QOL: symptoms, functional limitations, and emotions. We developed two versions of the pruritus QOL instrument, which assess for level of bother or frequency using items from the interviews and from generic skin QOL instruments, Skindex-16 (bother) and Skindex-29 (frequency). The instrument was tested for validity, reliability, and responsiveness. The frequency version was subsequently applied clinically to further evaluate its face validity.

Results: A total of 89 patients with dermatologic conditions participated in the validation phase and 101 patients participated in the clinical application phase of the study. Construct validity was demonstrated by principal axes factor analyses and by demonstrating that differences in symptoms, functioning, and emotion differed among the varying levels of self-reported pruritus severity more than would be expected by chance (P < .05 by analysis of variance). The instrument demonstrated reliability with internal consistency (Cronbach alpha: frequency 0.72-0.93 and bother 0.78-0.81) and reproducibility (intraclass correlation coefficient: frequency 0.91 and bother 0.84-0.87). The instrument suggested preliminary responsiveness for patients with improved disease for both frequency and bother items with both overall scores and the majority of the subscales scored demonstrating significant changes. Discriminant validity was shown by comparing differences in and the number of insensitive items between the pruritus-specific QOL instrument and the generic Skindex instruments.

Limitations: Lack of generalizability and potential selection bias are limitations.

Conclusions: This study represents, to our knowledge, the first attempt at a pruritus-specific QOL instrument that is reliable, valid, and responsive.

Citing Articles

Chronic kidney disease-associated pruritus and patient-centred outcomes: a systematic review.

Wang T, Goh J, Seth S, Do L, Tesfaye W, Sud K J Nephrol. 2025; .

PMID: 40000587 DOI: 10.1007/s40620-025-02221-9.


Patient-Reported Outcomes among people living with Chronic Pruritus (PROs-CP): Protocol for a single-center, multistage, mixed-methods prospective cohort study in Thailand.

Nochaiwong S, Ruengorn C, Kiratikanon S, Rujiwetpongstorn R, Chieosilapatham P, Tovanabutra N PLoS One. 2025; 20(2):e0314548.

PMID: 39928603 PMC: 11809786. DOI: 10.1371/journal.pone.0314548.


Practical guide for the diagnosis and treatment of localized and generalized cutaneous pruritus (chronic itch with no underlying pruritic dermatosis).

Hashimoto T, Okuno S J Dermatol. 2024; 52(2):204-220.

PMID: 39663861 PMC: 11807371. DOI: 10.1111/1346-8138.17565.


Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas.

Hu M, Scheffel J, Frischbutter S, Steinert C, Reidel U, Spindler M Clin Exp Med. 2024; 24(1):171.

PMID: 39068637 PMC: 11284195. DOI: 10.1007/s10238-024-01407-y.


Quantitative sensory testing in notalgia paresthetica reveals small fiber-type-specific differences in non-pruritic sensitivity: a pilot study.

Harper D, Chu L, Mustin D, Cole E Pain Rep. 2024; 9(4):e1162.

PMID: 38835743 PMC: 11146484. DOI: 10.1097/PR9.0000000000001162.